Based on the SMILES Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1, the molecule has a drug half life time in humans after IV administration of 1.200 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one